Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective
María Del Mar Mañú Pereira(Vall d'Hebron Institut de Recerca), Béatrice Gulbis(Université Libre de Bruxelles), Pierre Fenaux(Hôpital Avicenne), F. Galactéros(Assistance Publique – Hôpitaux de Paris), Elena Cela(Universidad Complutense de Madrid), Petros Kountouris(Cyprus Institute of Neurology and Genetics), Victoria Gutiérrez Valle(Vall d'Hebron Institut de Recerca), Joachim B. Kunz(Heidelberg University), Pablo Bartolucci(Université Paris-Est Créteil), Federico Álvarez(Universidad Politécnica de Madrid), Angelo Loris Brunetta(European Organisation for Rare Diseases), Antonis Kattamis, Soteroula Christou(Archbishop Makarios III Hospital), Celeste Bento(Hospitais da Universidade de Coimbra), Sara Reidel(Vall d'Hebron Institut de Recerca), Stephan Lobitz(Gemeinschaftsklinikum Mittelrhein), Anna Collado Gimbert(Vall d'Hebron Institut de Recerca), Raffaella Colombatti(University of Padua), Andreas Glenthøj(University of Copenhagen), Laurence Dedeken(Université Libre de Bruxelles), Corrina McMahon(University College Dublin), Giovanna Russo(University of Catania), Mariangela Pellegrini(Assistance Publique – Hôpitaux de Paris), Eduard J. van Beers(Utrecht University), Miriam Santos Freire(European Organisation for Rare Diseases), Mariane de Montalembert(Hôpital Necker-Enfants Malades)
Cited by 34
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k